Read + Share
Amedeo Smart
Independent Medical Education
Garrett N, Dintwe O, Monaco CL, Jones M, et al. Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial. J Acquir Immune Defic Syndr 2024;96:350-360.PMID: 38916429
Email
LinkedIn
Privacy Policy